New York, United States
Capsule, founded in 2016 and headquartered in the United States, is transforming the $425 billion pharmacy industry with its innovative approach. Positioned at the intersection of Health Care, Pharmaceutical, and Retail, Capsule leverages advanced technology to deliver customized healthcare outcomes for a diverse clientele, including doctors, hospitals, insurers, and manufacturers. The company's focus is on human-centric care, underscoring its commitment to nurturing relationships in the often impersonal healthcare system.
Having secured more than $500 million from top-tier healthcare and technology investors, Capsule's recent funding includes a $300 million Series D investment in April 2021. This round was led by distinguished investors such as T. Rowe Price, Baillie Gifford, Durable Capital Partners, Whale Rock Capital Management, and IPD Capital, LLC. Capsule's strategic capital deployment aims to solidify its market position and accelerate its mission to revamp pharmaceutical care.
